Afimmune Limited

The biopharma industry has high ambitions to improve therapies for patients across many disease categories, drawing on a wealth of technological advances that have been emerging and maturing in recent

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Corp. Advanced Cell Diagnostics Inc. Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Dia

Many targets and drugs are being evaluated for the treatment of non-alcoholic steatohepatitis (NASH), a form of non-alcoholic fatty liver disease (NAFLD), but no one really knows which will turn out b